We are live on ! Find out more
MJP

Michael J. Puzo Portfolio holdings

AUM $343M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$269M
AUM Growth
+$12.7M
Cap. Flow
+$4.21M
Cap. Flow %
1.56%
Top 10 Hldgs %
37.42%
Holding
89
New
9
Increased
22
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$1.14M
2
DIS icon
Walt Disney
DIS
+$888K
3
ALC icon
Alcon
ALC
+$539K
4
AMZN icon
Amazon
AMZN
+$514K
5
TXN icon
Texas Instruments
TXN
+$492K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$683K
2
ORCL icon
Oracle
ORCL
+$484K
3
XLNX
Xilinx Inc
XLNX
+$344K
4
MA icon
Mastercard
MA
+$318K
5
CVS icon
CVS Health
CVS
+$307K

Sector Composition

Rank Sector Weight
1 Healthcare 23.23%
2 Technology 21.31%
3 Industrials 13.22%
4 Financials 12%
5 Consumer Staples 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROK icon
26
Rockwell Automation
ROK
$51.4B
$3.76M 1.4%
22,954
+1,701
+8% +$287K
ILMN icon
27
Illumina
ILMN
$29.4B
$3.76M 1.4%
10,499
-214
-2% -$67.6K
CVS icon
28
CVS Health
CVS
$137B
$3.21M 1.19%
59,032
-5,701
-9% -$307K
EOG icon
29
EOG Resources
EOG
$78B
$3.2M 1.19%
34,342
+2,202
+7% +$205K
XYL icon
30
Xylem
XYL
$28.5B
$3.12M 1.16%
37,292
-53
-0.1% -$4.22K
PEP icon
31
PepsiCo
PEP
$186B
$2.94M 1.09%
22,431
-250
-1% -$32K
PYPL icon
32
PayPal
PYPL
$49.5B
$2.44M 0.91%
21,295
+1,475
+7% +$163K
BDX icon
33
Becton Dickinson
BDX
$43.1B
$2.28M 0.85%
9,261
+4,907
+113% +$1.14M
MRK icon
34
Merck
MRK
$324B
$2.14M 0.8%
26,758
-838
-3% -$64.2K
AMZN icon
35
Amazon
AMZN
$2.5T
$2.13M 0.79%
22,520
+5,520
+32% +$514K
MKC icon
36
McCormick & Company Non-Voting
MKC
$13.4B
$1.81M 0.67%
23,350
-350
-1% -$27K
OZK icon
37
Bank OZK
OZK
$5.49B
$1.64M 0.61%
54,430
-3,000
-5% -$93K
FTV icon
38
Fortive
FTV
$19B
$1.58M 0.59%
30,843
+3,647
+13% +$189K
EMR icon
39
Emerson Electric
EMR
$82.9B
$1.44M 0.53%
21,572
+2,750
+15% +$184K
V icon
40
Visa
V
$677B
$1.27M 0.47%
7,325
-1,280
-15% -$210K
ABBV icon
41
AbbVie
ABBV
$458B
$1.21M 0.45%
16,576
-250
-1% -$19.6K
ESBA icon
42
Empire State Realty Series ES
ESBA
$1.47B
$1.05M 0.39%
71,073
-3,000
-4% -$46.3K
RDS.A
43
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.01M 0.38%
15,600
– –
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.01M 0.38%
4,750
– –
IPGP icon
45
IPG Photonics
IPGP
$3.89B
$927K 0.34%
6,005
-300
-5% -$45.4K
ORCL icon
46
Oracle
ORCL
$331B
$852K 0.32%
14,950
-8,950
-37% -$484K
UNP icon
47
Union Pacific
UNP
$183B
$737K 0.27%
4,356
-544
-11% -$93.2K
PFE icon
48
Pfizer
PFE
$140B
$648K 0.24%
15,771
-1,133
-7% -$45K
CL icon
49
Colgate-Palmolive
CL
$72.6B
$636K 0.24%
8,867
-300
-3% -$21.3K
ALC icon
50
Alcon
ALC
$33.1B
$570K 0.21%
+9,187
New +$539K
1
2
3 4

Similar funds

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
LWM
Long Walk Management Greenwich, Connecticut $344M AUM 44.86% 1-Year Est. Return
CWM
Cedar Wealth Management Walnut Creek, California $344M AUM 18.78% 1-Year Est. Return
BA
Ballast Advisors Woodbury, Minnesota $344M AUM 16.81% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
SMG
Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return
FMB
Field & Main Bank Henderson, Kentucky $344M AUM 23.98% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $343M AUM 17.29% 1-Year Est. Return

Michael J. Puzo's Q2 2019 Portfolio in Review

As of Q2 2019, Michael J. Puzo held 89 positions worth $269M, up 5% from $257M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Michael J. Puzo's Q2 2019 filing shows 9 new, 22 increased, 41 reduced and 3 closed positions. Its largest new stake was Alcon: 9,187 shares worth $570K. The largest sale was Novartis, an estimated $683K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Michael J. Puzo's largest Q2 2019 buy was Alcon: 9,187 shares worth $570K.
  • Michael J. Puzo added most to Becton Dickinson in Q2 2019, an estimated $1.14M increase.
  • Michael J. Puzo's biggest Q2 2019 reduction was Novartis, cutting an estimated $683K.
  • Michael J. Puzo fully exited DuPont de Nemours in Q2 2019, selling an estimated $213K.
  • Michael J. Puzo's ten largest holdings make up 37% of its $269M portfolio in Q2 2019.
  • Michael J. Puzo opened 9 new positions and closed 3 in Q2 2019.
  • Michael J. Puzo's portfolio value rose 5% quarter-over-quarter to $269M.

Based on Michael J. Puzo's 13F filing for Q2 2019, filed 24 Jul 2019.